Clinical Trial Update: A Study of Staccato Loxapine (ADASUVE®) for Inhalation [Phase 3]

View source ↗

Summary

Phase 3 study update for Staccato Loxapine (ADASUVE) inhalation addressing psychomotor agitation and schizophrenia (potentially bipolar disorder).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Psychomotor Agitation
• Schizophrenia

Drugs mentioned

• Staccato Loxapine (ADASUVE) (Loxapine)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Psychomotor Agitation, Schizophrenia | Phase 3 | Status: UNKNOWN